Next to come - IND application.
"We arewithin days of filing our Investigational New Drug (IND) application with the United States Food and
Drug Administration (FDA), which will be an incredible accomplishment for the company and paves the way for
the initiation of recruitment in the HEALEY ALS Platform Trial in H1 CY2025."
Ann: Positive 8-month Interim Data from OLE Study, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $83.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 17.0¢ | $25.63K | 147.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 153125 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 10552 | 2 |
View Market Depth
| Last trade - 11.56am 23/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |